title: Hypocholesterolemic and antioxidative effects of naringenin and its two metabolites in high-cholesterol fed rats.
abstract: This study was conducted to compare the hypocholesterolemic and antioxidant effects of naringenin (0.02%), and its metabolites, rho-hyproxyphenylpropionic acid (PHPP, 0.012%) and rho-hydroxybenzoic acid (PHB, 0.012%), in 1% cholesterol diet-fed rats. All supplements significantly lowered the plasma total-cholesterol (total-C), triglyceride (TG) and atherogenic index, and hepatic cholesterol levels compared with the control group. The plasma high-density lipoprotein-cholesterol (HDL-C) concentration was significantly higher in these supplemented groups. However, PHB group only affected the reduction of hepatic TG content. The hydroxyl-3-methylglutaryl-coenzyme A reductase (HMGR) activity was significantly lower in all supplemented groups, whereas only the naringenin group reduced the acyl-coenzyme A:cholesterol acyltransferase (ACAT) activity compared with the control group. The fecal acidic sterol excretion and hepatic superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) activities were significantly higher in all supplemented groups. All supplements also significantly decreased the contents of plasma and hepatic thiobarbituric acid reactive substances (TBARS). Accordingly, it was considered that naringenin and its metabolites were effective on improving the cholesterol and antioxidant metabolism.
authors.affiliation: Institute of Genetic Engineering, Department of Food Science and Nutrition, Kyungpook National University, Daegu, Korea.
authors.forename: Seon-Min
authors.initials: SM
authors.lastname: Jeon
authors.forename: Hae Kyung
authors.initials: HK
authors.lastname: Kim
authors.forename: Hye-Jin
authors.initials: HJ
authors.lastname: Kim
authors.forename: Gyeong-Min
authors.initials: GM
authors.lastname: Do
authors.forename: Tae-Sook
authors.initials: TS
authors.lastname: Jeong
authors.forename: Yong Bok
authors.initials: YB
authors.lastname: Park
authors.forename: Myung-Sook
authors.initials: MS
authors.lastname: Choi
mesh_terms: D000818:Animals; D000924:Anticholesteremic Agents / Q000494:pharmacology*; D000975:Antioxidants / Q000494:pharmacology*; D002374:Catalase / Q000378:metabolism; D002784:Cholesterol / Q000097:blood; D002791:Cholesterol, Dietary / Q000008:administration & dosage*; D005243:Feces / Q000737:chemistry; D044950:Flavanones / Q000378:metabolism / Q000494:pharmacology*; D006903:Hydroxymethylglutaryl CoA Reductases / Q000097:blood; D015227:Lipid Peroxidation; D008099:Liver / Q000201:enzymology; D008297:Male; D010226:Parabens / Q000494:pharmacology*; D010666:Phenylpropionates / Q000494:pharmacology*; D000091402:Prohibitins; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D000924:Anticholesteremic Agents; D000975:Antioxidants; D002791:Cholesterol, Dietary; D044950:Flavanones; D010226:Parabens; C000717332:Phb protein, rat; D010666:Phenylpropionates; D000091402:Prohibitins; C008869:phloretic acid; D002784:Cholesterol; D006903:Hydroxymethylglutaryl CoA Reductases; D002374:Catalase; C005273:naringenin; C038193:4-hydroxybenzoic acid